undamentalytics Newsletter
Sign in

Institution

A16Z Capital Management, L.L.C.

13F for the quarter to June 30, 2026, filed August 14, 2026 · SEC CIK 1540358

Reported value
$14.2bn
100% in companies we cover
Positions we cover
18
Largest SPCX 90.0%
Copy, a year
+67.4%
S&P 500 +17.0%
Copy Sharpe ratio
1.24
S&P 500 0.85

How copying its 13F would have done

$10.0k$20.0k$40.0k 202420252026 $35.5k$14.7k
CopyS&P 500 $10,000 copying A16Z Capital Management, L.L.C.'s filed holdings in companies we cover from May 17, 2024, buying on the first trading day after each 13F was filed and holding until the next, against the S&P 500 (total return). Marked weekly, log scale. Before costs and taxes; misses trading within each quarter and anything 13F does not show (shorts, cash, bonds, non-US holdings).

Biggest drop −42.2% (S&P 500 −16.9%); beta 2.16; alpha +31.1% a year (t = 1.41); last 12 months +9.0% against +12.1%.

Reported value by quarter

A16Z Capital Management, L.L.C.: 13F reported value Total value of all positions in each quarter's 13F, as filed (values before 2023 were filed in thousands of dollars and are converted).
$0 $5B $10B $15B Reported value, 2023-12-31: $1.6B Reported value, 2024-03-31: $1.4B Reported value, 2024-06-30: $1.2B Reported value, 2024-09-30: $1.1B Reported value, 2025-09-30: $1.4B Reported value, 2025-12-31: $1.6B Reported value, 2026-03-31: $1.3B Reported value, 2026-06-30: $14.2B 2023-12-31 2024-06-30 2025-09-30 2026-06-30 $14.2B
View chart data
Period Reported value
2023-12-31 $1.6B
2024-03-31 $1.4B
2024-06-30 $1.2B
2024-09-30 $1.1B
2025-09-30 $1.4B
2025-12-31 $1.6B
2026-03-31 $1.3B
2026-06-30 $14.2B

Holdings and moves

CompanyShare of portfolioValueSharesChange in shares
SPCXSpace Exploration Technologies Corp89.97%$12.8bn74.86MNew
NAVNNavan, Inc.4.54%$645.4m28.22M0.0%
RVMDRevolution Medicines, Inc.1.21%$172.5m921.1K0.0%
METAMeta Platforms0.84%$119.7m212.5K0.0%
FIGFigma, Inc.0.76%$108.2m5.98M−62.6% Reduced
BIOABioage Labs, Inc.0.56%$79.2m3.23M0.0%
XYZBlock, Inc.0.54%$77.3m1.02M0.0%
ERASErasca, Inc.0.37%$52.4m2.86M0.0%
MAZEMaze Therapeutics, Inc.0.36%$50.8m1.70M0.0%
OMDAOmada Health, Inc.0.18%$25.3m1.15M−50.0% Reduced
NAUTNautilus Biotechnology, Inc.0.12%$16.9m9.06M−48.7% Reduced
RBLXRoblox Corp0.10%$14.9m274.6KNew
AKTSAktis Oncology, Inc.0.09%$13.4m415.0K0.0%
CAMPCamp4 Therapeutics Corp0.07%$9.3m2.13M0.0%
BTGOBitgo Holdings, Inc.0.02%$3.5m666.4K0.0%
KLRAKailera Therapeutics, Inc.0.02%$3.1m140.0KNew
DNAGinkgo Bioworks Holdings, Inc.0.01%$1.1m108.6K0.0%
IPSTIP Strategy Holdings, Inc.0.00%$9,7224.1KNew
CompanyBought (value)Shares
SPCXSpace Exploration Technologies Corp$12.8bn74.86M
RBLXRoblox Corp$14.9m274.6K
KLRAKailera Therapeutics, Inc.$3.1m140.0K
IPSTIP Strategy Holdings, Inc.$9,7224.1K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanySold (value)Shares
FIGFigma, Inc.−$181.4m−10.03M
OMDAOmada Health, Inc.−$25.3m−1.15M
NAUTNautilus Biotechnology, Inc.−$16.1m−8.59M

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

No positions in covered companies were sold out this quarter.

  • Industrials90.2%
  • Technology5.3%
  • Health Care3.0%
  • Communication Services0.9%
  • Financials0.6%
  • Consumer Staples0.0%

Share of the value held in companies we cover, by sector.

PeriodCopy, a yearS&P 500SharpeS&P 500Biggest dropBeta
Whole backtestMay 17, 2024 to November 2, 2026+67.4%+17.0%1.240.85−42.2%2.16
Last yearNovember 7, 2025 to November 2, 2026+20.8%+14.2%0.560.84−26.8%1.76

From SEC Form 13F data sets. A 13F lists long positions in US-listed shares at the quarter's end, filed up to 45 days later; it does not show shorts, cash, bonds, non-US holdings or trades within the quarter. Positions in companies outside our coverage are not listed here. Research, not investment advice.